Abstract:What is known and Objective: Cytochrome P450 2C19 (CYP2C19) and CYP2D6 are important xenobiotic metabolic enzymes and both show considerable genetic variability between Orientals and Caucasians. There are known marked heterogeneity in susceptibility to various cancers and hypertension among Chinese Mongolian, Hui and Han ethnic groups, but the molecular mechanisms are unknown. Our objective was to investigate the patterns of distribution of CYP2C19 and CYP2D6 polymorphisms among healthy Chinese subjects to determine whether any observed inter-ethnic variability might be worth further investigation as possible contributors to the known differences in disease prevalence. Methods: Blood samples were collected from 454 unrelated Chinese healthy subjects (214 Han, 111 Hui, 129 Mongolian) for genotyping analysis. The single nucleotide polymorphisms (SNPs) CYP2C19*2 (681G>A in exon 5), CYP2C19*3 (636G>A in exon 4) and CYP2D6*10 (188C>T in exon 1) were determined by the polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) method. Results and Discussion: Significantly higher frequencies of the CYP2C19 poor metabolic genotypes were observed in Chinese Han (18.7%), Chinese Hui (25.0%) and Chinese Mongolian (10.9%) subjects than has been reported for Caucasians (1.73.0%, P < 0.01). The prevalent defective allele CYP2C19*2 occurred more frequently in both Chinese Hui (32.4%) and Han (29.7%) than in Chinese Mongolian (18.2%, P < 0.01) subjects. The CYP2C19*2 and CYP2C19*3 defective alleles were significantly more frequent in Chinese Han and Chinese Hui ethnic groups than have been reported for Caucasians (11.116.3% and 00.2%, P < 0.01). CYP2D6*1/*10 heterozygotes and CYP2D6*10/*10 homozygotes were observed more frequently in Chinese Han (43.1% and 27.2%), Hui (40.6% and 30.7%) and Mongolian subjects (31.3% and 9.6%, both P < 0.01) than have been reported for Caucasians (5.5% and 0.3%, P < 0.01). In Chinese Mongolians, the CYP2D6*10 allele occurred at a frequency (25.2%, P < 0.01) intermediate between those reported for Caucasians and the other two Chinese ethnic populations. What is new and Conclusions: This is first report of interethnic differences in frequencies of functional CYP2C19 and CYP2D6 genes among Chinese Mongolian, Hui and Han populations. These differences may be important in explaining reported inter-ethnic differences in disease prevalence and response to drugs.

Frequency of CYP2D610 and 14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Determination of CYP2D610 And14 Genotypes by Amplification Refractory Mutation Methods in Chinese Subjects

Correlation of Genetic Polymorphism of Cytochrome P4502D6 with Dextromethorphan Oxidative Metabolism in Chinese.

Identification of CYP2D6 Impaired Functional Alleles in Mexican Americans.

CYP3A53 and CYP3A418 Single Nucleotide Polymorphisms in a Chinese Population.

[Allele specific amplification for CYP2D6 gene related to intermediate metabolizer in Chinese subjects].

Differences in Genotype and Allele Frequency Distributions of Polymorphic Drug Metabolizing Enzymes CYP2C19 and CYP2D6 in Mainland Chinese Mongolian, Hui and Han Populations

In Vitro and in Vivo Characterization of 13 CYP2C9 Allelic Variants Found in Chinese Han Population

The G-113a Polymorphism In Cyp1a2 Affects The Caffeine Metabolic Ratio In A Chinese Population

Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population

Genetic Polymorphisms of CYP2C8 and CYP2C9 in Chinese Type 2 Diabetes Mellitus

Frequencies of Poor Metabolizers of Cytochrome P450 2C19 in Esophagus Cancer, Stomach Cancer, Lung Cancer and Bladder Cancer in Chinese Population

In Vitro Functional Assessment of 22 Newly Identified CYP2D6 Allelic Variants in the Chinese Population.

Influence of Cyp2d6*10b Genotype on Pharmacokinetics of Propafenone Enantiomers in Chinese Subjects

Genetic and Phenotypic Frequency Distribution of CYP2C9, CYP2C19 and CYP2D6 in over 3200 Han Chinese

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

Identification and Functional Assessment of Eight CYP3A4 Allelic Variants 39-46 Detected in the Chinese Han Population

[Polymorphisms of Drug-Metabolizing Enzymes Genes in a Han Chinese Population].

Allelic Distributions of CYP2D6 Gene Copy Number Variation in the Eastern Han Chinese Population

Frequencies of Genotypes and Alleles of the Functional SNPs in CYP2C19 and CYP2E1 in Mainland Chinese Kazakh, Uygur and Han Populations

Frequency of CYP2D6*10 and *14 Alleles and Their Influence on the Metabolic Activity of CYP2D6 in a Healthy Chinese Population

Identification and Functional Assessment of EightCYP3A4Allelic Variants*39–*46Detected in the Chinese Han Population

Determination of CYP2D6*10 And*14 Genotypes by Amplification Refractory Mutation Methods in Chinese Subjects